pRetroSuper Smad3 Citations (6)

Originally described in: Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway.
He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massague J Cell. 2006 Jun 2. 125(5):929-41. PubMed Journal

---

Articles Citing pRetroSuper Smad3

Articles
TGF-beta1 stimulates mouse macrophages to express APRIL through Smad and p38MAPK/CREB pathways. Jang YS, Kim JH, Seo GY, Kim PH. Mol Cells. 2011 Sep;32(3):251-5. doi: 10.1007/s10059-011-1040-4. Epub 2011 Jun 23. PubMed
HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Wardwell-Ozgo J, Dogruluk T, Gifford A, Zhang Y, Heffernan TP, van Doorn R, Creighton CJ, Chin L, Scott KL. Oncogene. 2014 Feb 20;33(8):1017-26. doi: 10.1038/onc.2013.30. Epub 2013 Feb 25. PubMed
Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT. Zhou HH, Chen L, Liang HF, Li GZ, Zhang BX, Chen XP. Int J Mol Sci. 2016 Apr 22;17(4). pii: E610. doi: 10.3390/ijms17040610. PubMed
STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence. Bryson BL, Junk DJ, Cipriano R, Jackson MW. Cell Cycle. 2016 Nov 28:1-16. doi: 10.1080/15384101.2016.1259037. PubMed
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling. Junk DJ, Bryson BL, Smigiel JM, Parameswaran N, Bartel CA, Jackson MW. Oncogene. 2017 Jul 13;36(28):4001-4013. doi: 10.1038/onc.2017.33. Epub 2017 Mar 13. PubMed
Aberrant Induction of a Mesenchymal/Stem Cell Program Engages Senescence in Normal Mammary Epithelial Cells. Bryson BL, Tamagno I, Taylor SE, Parameswaran N, Chernosky NM, Balasubramaniam N, Jackson MW. Mol Cancer Res. 2021 Apr;19(4):651-666. doi: 10.1158/1541-7786.MCR-19-1181. Epub 2020 Dec 22. PubMed

If you have published an article using this material, please email us at to have your article added to this page.